Thu, 13 Sep 2018 10:55:45 GMT
Takeda considers Shire's unit sale to cut debt
Japan's Takeda Pharmaceuticals is weighing a sale of Shire's eye care business unit, right after closing a $62B purchase of the British drugmaker, as it seeks to reduce the debt raised to finance the deal.